The $1.24 Billion Reason Why Kura Oncology Stock Is Up TodayBarchart Option·Aug 25 at 03:40 PMKURA-0.08%
Can Komzifti's Early Adoption Support Kura Oncology's Next Phase Of Growth?rttnews·Aug 25 at 09:13 AMKURA-0.08%
The Market's Junk Drawer: Sorting the Real Players from the NoiseGlobal Report·Aug 25 at 06:33 AMCALM-1.61%TOYO-6.65%
BNY Mellon's Tokenization Bet and Norwegian Cruise Line's Reality CheckGlobal Report·Aug 25 at 04:20 AMNCLH-3.06%KURA-0.08%
5 After-Hours Healthcare Gainers: AMIX, PMI, TENX, KURA, NEPHrttnews·Aug 24 at 09:10 PMTENX-13.62%AMIX-9.21%
Kura Oncology CEO Troy Wilson acquires 100,000 common shares valued at $1,239,000PUBT·Aug 24 at 04:30 PMKURA-0.08%
Kura Oncology Chief Commercial Officer Brian T. Powl sells 4,345 common shares for USD 51,656.85PUBT·Aug 24 at 04:30 PMKURA-0.08%
Kura Oncology CEO Troy Wilson reports purchase of 100,000 common shares worth $1.11 millionPUBT·Aug 17 at 03:45 PMKURA-0.08%
Kura Oncology (KURA) Q2 2026 Earnings Call: KOMZIFTI Sales Reach $9.1MTradingKey·Aug 14 at 03:24 AMKURA-0.08%
Kura Oncology, Inc. Stock 12‑Month Price Target Raised to $32, Implies 222% UpsideTradingView·Aug 13 at 10:20 AMKURA-0.08%
